期刊语言：英语

出版地区：美国

万维提示

1、投稿方式：在线投稿。

2、期刊网址：https://www.springer.com/journal/262

3、投稿网址：https://www.editorialmanager.com/ciim

4、官网邮箱：Dong.Haidong@mayo.edu（主编）

（更多相关咨询邮箱如下）

5、期刊刊期：月刊，一年出版12期。

2022年1月11日星期二

期刊相关咨询邮箱【官网信息】

Contact the journal

Submission-related enquiries

Queries about submission issues, peer review process, or the status of your manuscript should be sent to Karthiga Anbalagan (Karthiga.Anbalagan@springernature.com).

Production-related enquiries

Queries about accepted manuscripts in production or post-publication corrections should be sent to Anburaj Sundaram (Anburaj.Sundaram@springer.com).

Rights and Permissions enquiries

For permission requests to reuse or reprint content, please follow the link ‘Rights and permissions’ on the relevant article page. For other queries, contact journalpermissions@springernature.com.

Publication-related enquiries

Queries related to journal publishing should be sent to Mehak Massand (mehak.massand@springer.com).

投稿须知【官网信息】

Cancer Immunology, Immunotherapy

Submission guidelines

Instructions for Authors

Types of Papers

The journal Cancer Immunology, Immunotherapy publishes the following types of papers:

o Original research articles – featuring three innovations: new concept, new mechanism or new therapy, in basic science and clinical studies, text limit 4000 words, 45 references, 8 figures/3 tables limit.

o Brief research reports – featuring clear and concise conclusion supported by solid data at small-scale basic research or early stage of clinical studies, 2000 words, 20 references, 4 figure limit / 2 table limit.

o Review – featuring commentary, opinion, meeting summary. The objective is to provide a balanced, comprehensive review of current knowledge and advances on certain topics or technology, limit 4000 words, 40 references and 2 explanatory items (figure / table).

o Letter to the Editors – This journal occasionally accepts letters to the Editors pertaining primarily to articles published in the Journal. Text is limited to 750 words, with no abstract and no keywords. There may be one figure, up to five references, and no more than three authors, with author affiliations only including main institution, place name and (state plus) country (i.e. no departments, etc.).

o Meta-analysis Reviews - Must be based on a rigorous methodological/statistical approach described in detail in the methods section applied to a relevant clinical or basic research issue. Word limit is 3000 with no more than 100 references. Meta-Analyses and systematic reviews must adhere to the recommendations of the PRISMA document (http://prisma-statment.org).

o Clinical Trial Reports – please review the

guidelines of Original research Articles and include relevant immunological data.

o Editorials- it is a forum for exchanging ideas, innovations, new updates in a fast-moving field or topic. Word limitation 1200 with up to 10 references and one figure or table.

Manuscript Submission

Submission of a manuscript implies: that the work described has not been published before; that it is not under consideration for publication anywhere else; that its publication has been approved by all co-authors, if any, as well as by the responsible authorities – tacitly or explicitly – at the institute where the work has been carried out. The publisher will not be held legally responsible should there be any claims for compensation.

Permissions

Authors wishing to include figures, tables, or text passages that have already been published elsewhere are required to obtain permission from the copyright owner(s) for both the print and online format and to include evidence that such permission has been granted when submitting their papers. Any material received without such evidence will be assumed to originate from the authors.

Online Submission

Please follow the hyperlink “Submit manuscript” on the right and upload all of your manuscript files following the instructions given on the screen.

Please ensure you provide all relevant editable source files. Failing to submit these source files might cause unnecessary delays in the review and production process.

……

更多详情：

https://www.springer.com/journal/262/submission-guidelines